ロード中...
Transcriptome-wide study of TNF-inhibitor therapy in rheumatoid arthritis reveals early signature of successful treatment
BACKGROUND: Despite the success of TNF-inhibitor therapy in rheumatoid arthritis treatment, up to 40% of patients fail to respond adequately. This study aimed to identify transcriptome-based biomarkers of adalimumab response in rheumatoid arthritis (RA) to aid timely switching in non-responder patie...
保存先:
| 出版年: | Arthritis Res Ther |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7948368/ https://ncbi.nlm.nih.gov/pubmed/33691749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-021-02451-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|